This destructive act by OGT against Nrf2 may be blocked (Point 11) by the action of miR-181d—an inhibitor of OGT [22] found to target the 3’UTR of OGT mRNA to prevent OGT expression in ovarian cancer, elevating Nrf2 activation and providing cisplatin resistance. This evidence concerns the gene NFE2L2 and ovarian cancer.